Treatment options for lactic acidosis and metabolic crisis in children with mitochondrial disease

Journal of Inherited Metabolic Disease

Volumn 38, Issue 3, 2015, Pages 467-475

  Danhauser, Katharina ^a   Smeitink, Jan A M ^b   Freisinger, Peter ^c   Sperl, Wolfgang ^d   Sabir, Hemmen ^a   Hadzik, Berit ^a   Mayatepek, Ertan ^a   Morava, Eva ^e   Distelmaier, Felix ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Klinikum Reutlingen   (Germany)

^d PARACELSUS MEDICAL UNIVERSITY   (Austria)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRUVIC ACID;

ACIDOSIS, LACTIC; CHILD; DISEASE MANAGEMENT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; HYPOTHERMIA; METABOLISM; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

ACIDOSIS, LACTIC; CHILD; CHILD, PRESCHOOL; DISEASE MANAGEMENT; HUMANS; HYPOTHERMIA; MITOCHONDRIAL DISEASES; OXIDATION-REDUCTION; PYRUVIC ACID;

EID: 84939995817     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-014-9796-2     Document Type: Article

References (83)

1. Abdelmalak M, Lew A, Ramezani R et al (2013) Long-term safety of dichloroacetate in congenital lactic acidosis. Mol Genet Metab 109(2):139–143
2. Ahmad A, Kahler SG, Kishnani PS et al (1999) Treatment of pyruvate carboxylase deficiency with high doses of citrate and aspartate. Am J Med Genet 87(4):331–338
3. Andrade OV, Ihara FO, Troster EJ (2007) Metabolic acidosis in childhood: why, when and how to treat. J Pediatr (Rio J) 83(2 Suppl):S11–S21
4. Arieff AI (1994) Dialysis disequilibrium syndrome: current concepts on pathogenesis and prevention. Kidney Int 45(3):629–635
5. Arnon S, Litmanovits I, Regev R, Elpeleg O, Dolfin T (2001) Dichloroacetate treatment for severe refractory metabolic acidosis during neonatal sepsis. Pediatr Infect Dis J 20(2):218–219
6. Aschner JL, Poland RL (2008) Sodium bicarbonate: basically useless therapy. Pediatrics 122(4):831–835
7. Baertling F, Rodenburg RJ, Schaper J et al (2014) A guide to diagnosis and treatment of Leigh syndrome. J Neurol Neurosurg Psychiatry 85(3):257–265
8. Basu RK, Wheeler DS, Goldstein S, Doughty L (2011) Acute renal replacement therapy in pediatrics. Int J Nephrol 2011:785392
9. Berendzen K, Theriaque DW, Shuster J, Stacpoole PW (2006) Therapeutic potential of dichloroacetate for pyruvate dehydrogenase complex deficiency. Mitochondrion 6(3):126–135
10. Berg CS, Barnette AR, Myers BJ, Shimony MK, Barton AW, Inder TE (2010) Sodium bicarbonate administration and outcome in preterm infants. J Pediatr 157(4):684–687
11. Berthet C, Lei H, Thevenet J, Gruetter R, Magistretti PJ, Hirt L (2009) Neuroprotective role of lactate after cerebral ischemia. J Cereb Blood Flow Metab 29(11):1780–1789
12. Beveridge CJ, Wilkinson AR (2006) Sodium bicarbonate infusion during resuscitation of infants at birth. Cochrane Database Syst Rev 1:CD004864
13. Bousounis DP, Camfield PR, Wolf B (1993) Reversal of brain atrophy with biotin treatment in biotinidase deficiency. Neuropediatrics 24(4):214–217
14. Bridges BC, Askenazi DJ, Smith J, Goldstein SL (2012) Pediatric renal replacement therapy in the intensive care unit. Blood Purif 34(2):138–148
15. Cuthbert C, Alberti KG (1978) Acidemia and insulin resistance in the diabetic ketoacidotic rat. Metabolism 27(12 Suppl 2):1903–1916
16. Debray FG, Lambert M, Chevalier I et al (2007) Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases. Pediatrics 119(4):722–733
17. Distelmaier F, Huppke P, Pieperhoff P, et al (2013) Biotin-responsive basal ganglia disease: a treatable differential diagnosis of leigh syndrome. JIMD reports
18. Enns GM, Bennett MJ, Hoppel CL et al (2000) Mitochondrial respiratory chain complex I deficiency with clinical and biochemical features of long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. J Pediatr 136(2):251–254
19. Felig P (1973) The glucose-alanine cycle. Metabolism 22(2):179–207
20. Ferriero R, Manco G, Lamantea E et al (2013) Phenylbutyrate therapy for pyruvate dehydrogenase complex deficiency and lactic acidosis. Sci Transl Med 5(175):175ra131
21. Gehlbach BK, Schmidt GA (2004) Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit - the role of buffers. Crit Care 8(4):259–265
22. Gerards M, van den Bosch BJ, Danhauser K et al (2011) Riboflavin-responsive oxidative phosphorylation complex I deficiency caused by defective ACAD9: new function for an old gene. Brain 134(Pt 1):210–219
23. Glaser N, Barnett P, McCaslin I et al (2001) Risk factors for cerebral edema in children with diabetic ketoacidosis. The pediatric emergency medicine collaborative research committee of the American academy of pediatrics. N Engl J Med 344(4):264–269
24. Halperin ML, Cheema-Dhadli S, Halperin FA, Kamel KS (1994) Rationale for the use of sodium bicarbonate in a patient with lactic acidosis due to a poor cardiac output. Nephron 66(3):258–261
25. Hatherill M, Waggie Z, Purves L, Reynolds L, Argent A (2003) Mortality and the nature of metabolic acidosis in children with shock. Intensive Care Med 29(2):286–291
26. Herrera L, Kazemi H (1980) CSF bicarbonate regulation in metabolic acidosis: role of HCO3- formation in CNS. J Appl Physiol Respir Environ Exerc Physiol 49(5):778–783
27. Holmdahl MH, Wiklund L, Wetterberg T et al (2000) The place of THAM in the management of acidemia in clinical practice. Acta Anaesthesiol Scand 44(5):524–527
28. Honzik T, Tesarova M, Mayr JA et al (2010) Mitochondrial encephalocardio-myopathy with early neonatal onset due to TMEM70 mutation. Arch Dis Child 95(4):296–301
29. Huang YG, Wong KC, Yip WH, McJames SW, Pace NL (1995) Cardiovascular responses to graded doses of three catecholamines during lactic and hydrochloric acidosis in dogs. Br J Anaesth 74(5):583–590
30. Infante JP, Huszagh VA (2000) Secondary carnitine deficiency and impaired docosahexaenoic (22:6n-3) acid synthesis: a common denominator in the pathophysiology of diseases of oxidative phosphorylation and beta-oxidation. FEBS Lett 468(1):1–5
31. Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG (2013) Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 1:CD003311
32. Kaufmann P, Engelstad K, Wei Y et al (2006) Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology 66(3):324–330
33. Kecskes ZB, Davies MW (2002) Rapid correction of early metabolic acidaemia in comparison with placebo, no intervention or slow correction in LBW infants. Cochrane Database Syst Rev 1:CD002976
34. Kellum JA, Song M, Li J (2004a) Science review: extracellular acidosis and the immune response: clinical and physiologic implications. Crit Care 8(5):331–336
35. Kellum JA, Song M, Venkataraman R (2004b) Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest 125(1):243–248
36. Kennedy AC, Linton AL, Eaton JC (1962) Urea levels in cerebrospinal fluid after haemodialysis. Lancet 1(7226):410–411
37. Klepper J, Leiendecker B, Bredahl R et al (2002) Introduction of a ketogenic diet in young infants. J Inherit Metab Dis 25(6):449–460
38. Koene S, Rodenburg RJ, van der Knaap MS et al (2012) Natural disease course and genotype-phenotype correlations in Complex I deficiency caused by nuclear gene defects: what we learned from 130 cases. J Inherit Metab Dis 35(5):737–747
39. Koopman WJ, Willems PH, Smeitink JA (2012) Monogenic mitochondrial disorders. N Engl J Med 366(12):1132–1141
40. Kowalchuk JM, Maltais SA, Yamaji K, Hughson RL (1989) The effect of citrate loading on exercise performance, acid-base balance and metabolism. Eur J Appl Physiol Occup Physiol 58(8):858–864
41. Kraut JA, Madias NE (2012) Treatment of acute metabolic acidosis: a pathophysiologic approach. Nat Rev Nephrol 8(10):589–601
42. Kurlemann G, Paetzke I, Moller H et al (1995) Therapy of complex I deficiency: peripheral neuropathy during dichloroacetate therapy. Eur J Pediatr 154(11):928–932
43. Lardner A (2001) The effects of extracellular pH on immune function. J Leukoc Biol 69(4):522–530
44. Leary SC, Antonicka H, Sasarman F et al (2013) Novel Mutations in SCO1 as a cause of fatal infantile encephalopathy and lactic acidosis. Hum Mutat 34(10):1366–1370
45. Lim S (2007) Metabolic acidosis. Acta Med Indones 39(3):145–150
46. Manzanares W, Hardy G (2011) Thiamine supplementation in the critically ill. Curr Opin Clin Nutr Metab Care 14(6):610–617
47. Mayr JA, Freisinger P, Schlachter K et al (2011) Thiamine pyrophosphokinase deficiency in encephalopathic children with defects in the pyruvate oxidation pathway. Am J Hum Genet 89(6):806–812
48. McBryde KD, Kershaw DB, Bunchman TE et al (2006) Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism. J Pediatr 148(6):770–778
49. McNaughton LR (1990) Sodium citrate and anaerobic performance: implications of dosage. Eur J Appl Physiol Occup Physiol 61(5–6):392–397
50. Mitchell JH, Wildenthal K, Johnson RL Jr (1972) The effects of acid-base disturbances on cardiovascular and pulmonary function. Kidney Int 1(5):375–389
51. Mizock BA (1989) Lactic acidosis. Dis Mon 35(4):233–300
52. Mochel F, DeLonlay P, Touati G et al (2005) Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. Mol Genet Metab 84(4):305–312
53. Nahas GG, Sutin KM, Fermon C et al (1998) Guidelines for the treatment of acidaemia with THAM. Drugs 55(2):191–224
54. O’Regan RG, Majcherczyk S (1982) Role of peripheral chemoreceptors and central chemosensitivity in the regulation of respiration and circulation. J Exp Biol 100:23–40
55. Orchard CH, Cingolani HE (1994) Acidosis and arrhythmias in cardiac muscle. Cardiovasc Res 28(9):1312–1319
56. Orchard CH, Kentish JC (1990) Effects of changes of pH on the contractile function of cardiac muscle. Am J Physiol 258(6 Pt 1):C967–C981
57. Parikh S, Saneto R, Falk MJ, Anselm I, Cohen BH, Haas R, Medicine Society TM (2009) A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 11(6):414–30
58. Parker MJ, Parshuram CS (2013) Sodium bicarbonate use in shock and cardiac arrest: attitudes of pediatric acute care physicians*. Crit Care Med 41(9):2188–2195
59. Patel MS, Korotchkina LG (2006) Regulation of the pyruvate dehydrogenase complex. Biochem Soc Trans 34(Pt 2):217–222
60. Pfeffer G, Majamaa K, Turnbull DM, Thorburn D, Chinnery PF (2012) Treatment for mitochondrial disorders. Cochrane Database Syst Rev 4:CD004426
61. Pfeffer G, Horvath R, Klopstock T et al (2013) New treatments for mitochondrial disease-no time to drop our standards. Nat Rev Neurol 9(8):474–481
62. Prietsch V, Lindner M, Zschocke J, Nyhan WL, Hoffmann GF (2002) Emergency management of inherited metabolic diseases. J Inherit Metab Dis 25(7):531–546
63. Rango M, Arighi A, Bonifati C, Del Bo R, Comi G, Bresolin N (2014) The brain is hypothermic in patients with mitochondrial diseases. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 34(5):915–920
64. Roberton NR (1970) Apnoea after THAM administration in the newborn. Arch Dis Child 45(240):206–214
65. Robinson BH (2006) Lactic acidemia and mitochondrial disease. Mol Genet Metab 89(1–2):3–13
66. Roe CR, Mochel F (2006) Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential. J Inherit Metab Dis 29(2–3):332–340
67. Rotig A (2014) Genetics of mitochondrial respiratory chain deficiencies. Revue neurologique
68. Rotig A, Appelkvist EL, Geromel V et al (2000) Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356(9227):391–395
69. Sabatini S, Kurtzman NA (2009) Bicarbonate therapy in severe metabolic acidosis. J Am Soc Nephrol 20(4):692–695
70. Sato Y, Mutoh H, Suzuki M, Takekuma Y, Iseki K, Sugawara M (2013) Emulsification using highly hydrophilic surfactants improves the absorption of orally administered coenzyme Q10. Biol Pharm Bull 36(12):2012–2017
71. Schaefer AM, McFarland R, Blakely EL et al (2008) Prevalence of mitochondrial DNA disease in adults. Ann Neurol 63(1):35–39
72. Sheridan RL, Yu YM, Prelack K, Young VR, Burke JF, Tompkins RG (1998) Maximal parenteral glucose oxidation in hypermetabolic young children: a stable isotope study. JPEN J Parenter Enteral Nutr 22(4):212–216
73. Stacpoole PW (1989) The pharmacology of dichloroacetate. Metab Clin Exp 38(11):1124–1144
74. Stacpoole PW, Gilbert LR, Neiberger RE et al (2008a) Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate. Pediatrics 121(5):e1223–e1228
75. Stacpoole PW, Kurtz TL, Han Z, Langaee T (2008b) Role of dichloroacetate in the treatment of genetic mitochondrial diseases. Adv Drug Deliv Rev 60(13–14):1478–1487
76. Staub F, Winkler A, Haberstok J et al (1996) Swelling, intracellular acidosis, and damage of glial cells. Acta Neurochir Suppl 66:56–62
77. Tarnopolsky MA, Raha S (2005) Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med Sci Sports Exerc 37(12):2086–2093
78. Thorburn DR (2004) Mitochondrial disorders: prevalence, myths and advances. J Inherit Metab Dis 27(3):349–362
79. Tsai IJ, Hwu WL, Huang SC et al (2014) Efficacy and safety of intermittent hemodialysis in infants and young children with inborn errors of metabolism. Pediatr Nephrol 29(1):111–116
80. Walker BG, Phear DN, Martin FI, Baird CW (1963) Inhibition of insulin by acidosis. Lancet 2(7315):964–965
81. Wexler ID, Hemalatha SG, McConnell J et al (1997) Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations. Neurology 49(6):1655–1661
82. Wolf B (2012) Biotinidase deficiency: “if you have to have an inherited metabolic disease, this is the one to have”. Genet Med Off J Am Coll Med Genet 14(6):565–575
83. Wyss MT, Jolivet R, Buck A, Magistretti PJ, Weber B (2011) In vivo evidence for lactate as a neuronal energy source. J Neurosci 31(20):7477–7485